207 filings
Page 2 of 11
8-K
st6h0 jkd1bjfe
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
gy1uloxu
19 Jul 23
Regulation FD Disclosure
9:21am
8-K
45dfqom7 zmv
7 Jul 23
Entry into a Material Definitive Agreement
5:49pm
424B3
65uw2xhixx tp
29 Jun 23
Prospectus supplement
4:31pm
EFFECT
0tfnn
29 Jun 23
Notice of effectiveness
12:15am
CORRESP
8k1cwa3sb9u97
27 Jun 23
Correspondence with SEC
12:00am
UPLOAD
5motk8m
22 Jun 23
Letter from SEC
12:00am
8-K
doztmveahm zo082b
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
81kudgn5hjr26fqhx
26 May 23
Entry into a Material Definitive Agreement
5:02pm
8-K/A
0tf 9wgcn7
26 May 23
Financial Statements and Exhibits
7:01am
NT 10-Q
zqbpx o44vuy3i
16 May 23
Notice of late quarterly filing
8:57am
8-K
3b89p9c
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
8-K/A
akbthp1tu q5qd4
26 Apr 23
Financial Statements and Exhibits
5:02pm
RW
fdzz ccokor
22 Mar 23
Registration withdrawal request
9:16pm
8-K
kuxf710
13 Feb 23
Transaction Expected to Be Accretive to Earnings Through Profit Sharing Agreement
9:00am
8-K
j6re34l3dpbh97aoa
23 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
k6ljpgiy
11 Jan 23
Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors
9:00am